cell
plasmid
kindli
provid
dr
c
rice
rockefel
univers
new
york
ny
usa
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fb
biowest
franc
amino
acid
invitrogen
carlsbad
ca
usa
penicillin
iuml
streptomycin
invitrogen
incub
cell
strain
hcv
genotyp
prepar
describ
previous
use
studi
moi
g
uralensi
root
purchas
tochimoto
tenkaido
osaka
japan
methanol
extract
g
uralensi
root
prepar
subject
purif
procedur
describ
previous
brief
g
uralensi
root
dri
room
temperatur
pulver
extract
methanol
hr
extract
filter
filtrat
concentr
use
evapor
temperatur
exceed
residu
obtain
water
success
partit
chloroform
chloroform
extract
subject
recycl
prepar
hplc
solvent
system
methanol
column
mm
id
mm
flow
rate
mlmin
detect
uv
nm
condit
afford
fraction
subject
hplc
separ
solvent
system
column
imtakt
unison
kyoto
japan
mm
id
mm
flow
rate
mlmin
detect
uv
nm
give
fraction
glycyrin
mg
purifi
recycl
hplc
condit
afford
glycycoumarin
mg
combin
hplc
solvent
system
column
imtakt
unison
mm
id
mm
flow
rate
mlmin
detect
uv
nm
give
fraction
subject
recycl
hplc
condit
give
liquiritigenin
mg
purifi
recycl
hplc
condit
afford
glycyrol
mg
spectra
measur
jeol
eca
spectromet
mhz
tokyo
japan
hplc
perform
plu
system
tokyo
japan
glycyrrhiz
acid
cat
glycyrrhiz
acid
salt
cat
glycyrrhetin
acid
cat
glabridin
cat
purchas
wako
pure
chemic
industri
osaka
japan
liquiritin
cat
liquiritigenin
cat
licochalcon
cat
purchas
tokyo
japan
isoliquiritigenin
cat
tokyo
chemic
industri
tokyo
japan
cat
cat
glycyrrhet
acid
cat
purchas
funakoshi
tokyo
japan
glycycoumarin
glycyrol
glycyrin
liquiritigenin
isol
g
uralensi
extract
studi
describ
test
sampl
weigh
dissolv
dmso
obtain
stock
solut
mgml
stock
solut
store
use
cell
seed
plate
cellswel
hcv
mix
serial
dilut
test
sampl
inocul
cell
hr
cell
wash
medium
remov
residu
viru
incub
medium
contain
concentr
sampl
viru
inocul
experi
treatment
sampl
perform
viru
inocul
order
assess
mode
action
sampl
examin
cultur
supernat
collect
day
titrat
viru
infect
describ
viru
cell
treat
medium
contain
dmso
serv
control
percent
inhibit
viru
infect
dilut
sampl
calcul
comparison
control
determin
viru
sampl
dilut
serial
complet
medium
inocul
onto
cell
seed
glass
coverslip
plate
viru
adsorpt
hr
cell
wash
medium
remov
residu
viru
cultur
hr
cell
stain
indirect
immunofluoresc
method
report
previous
brief
cell
wash
pb
fix
paraformaldehyd
min
permeabil
triton
pb
min
room
temperatur
wash
three
time
pb
cell
incub
patient
serum
hr
follow
incub
goat
igg
mbl
nagoya
japan
cell
counterstain
hoechst
molecular
probe
eugen
usa
min
cell
count
fluoresc
microscop
keyenc
osaka
japan
cytotox
sampl
assess
assay
describ
previous
slight
modif
brief
cell
plate
treat
serial
dilut
sampl
dmso
control
hr
end
treatment
reagent
roch
mannheim
germani
ad
well
cell
cultur
hr
reagent
absorb
cell
convert
formazan
mitochondri
dehydrogenas
amount
formazan
correl
number
live
cell
determin
measur
absorb
well
use
micropl
reader
nm
percent
cell
viabil
compar
control
calcul
dilut
sampl
determin
cell
lyse
sd
sampl
buffer
equal
amount
protein
subject
gel
electrophoresi
transfer
onto
polyvinyliden
difluorid
membran
millipor
bedford
usa
describ
previous
membran
incub
respect
primari
antibodi
primari
antibodi
use
mous
monoclon
antibodi
hcv
gapdh
millipor
horseradish
goat
immunoglobulin
invitrogen
use
visual
respect
protein
mean
enhanc
chemiluminesc
detect
system
ecl
ge
healthcar
buckinghamshir
uk
quantit
perform
describ
previous
brief
total
rna
extract
cell
use
reliaprep
rna
cell
miniprep
system
promega
madison
wi
usa
accord
manufactur
instruct
one
microgram
total
rna
revers
transcrib
use
goscript
revers
transcript
system
promega
random
primer
subject
quantit
pcr
analysi
use
sybr
premix
ex
taq
takara
kyoto
japan
microamp
reaction
plate
abi
prism
system
appli
biosystem
foster
citi
ca
usa
primer
amplifi
region
viral
genom
sens
antisens
human
gapdh
gene
express
measur
use
primer
sens
serv
intern
control
first
examin
crude
methanol
extract
g
uralensi
root
activ
use
hcv
strain
cell
valu
crude
methanol
extract
respect
select
index
si
tabl
partit
methanol
extract
use
differ
solvent
found
activ
concentr
chloroform
partit
whose
respect
si
next
chloroform
partit
use
recycl
hplc
examin
activ
found
signific
activ
fraction
rang
tabl
tri
purifi
major
compon
fraction
use
recycl
hplc
identifi
glycycoumarin
glycyrin
glycyrol
liquiritigenin
nmr
spectrum
analysi
data
shown
examin
purifi
compound
obtain
g
uralensi
extract
glycycoumarin
glycyrin
glycyrol
liquiritigenin
chemic
compound
glycyrrhizin
deriv
found
glycyrrhizin
glycyrrhiz
acid
monoammonium
salt
glycyrrhiz
acid
monoammonium
latter
former
possess
margin
activ
valu
respect
tabl
aglycon
glycyrrhizin
glycyrrhetin
acid
show
signific
activ
glycyrrhizin
note
activ
weaker
recycl
hplc
fraction
g
uralensi
extract
monoglucuronid
form
glycyrrhizin
glycyrrhet
acid
show
signific
activ
concentr
test
result
suggest
anoth
compound
fraction
respons
activ
two
saponin
test
studi
show
detect
activ
hand
coumarin
glycycoumarin
glycyrin
glycyrol
isol
studi
puriti
g
uralensi
extract
show
potent
activ
liquiritigenin
also
isol
g
uralensi
extract
show
weaker
activ
coumarin
also
isoliquiritigen
licochalcon
glabridin
exhibit
potent
activ
respect
note
licochalcon
glabridin
report
absent
g
uralensi
present
g
inflata
g
glabra
determin
whether
effect
compound
glycyrrhiza
speci
exert
entri
stage
perform
follow
experi
hcv
mix
test
compound
mixtur
inocul
cell
viru
adsorpt
hr
residu
viru
test
sampl
remov
cell
fresh
medium
without
test
sampl
hr
experi
examin
antivir
effect
entri
stephcv
inocul
cell
absenc
test
sampl
viru
adsorpt
hr
residu
viru
remov
cell
treat
test
sampl
hr
experi
examin
antivir
effect
stepa
posit
control
hcv
mix
test
sampl
inocul
cell
viru
adsorpt
hr
residu
viru
test
sampl
remov
cell
treat
test
sampl
hr
found
glycyrrhiza
compound
well
chloroform
partit
g
uralensi
extract
exert
antivir
effect
viru
inocul
tabl
result
suggest
compound
glycyrrhiza
speci
test
studi
name
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isoliquiritigenin
licochalcon
glabridin
well
chloroform
extract
act
primarili
step
confirm
g
compound
exert
activ
step
cell
inocul
hcv
hr
follow
treatment
compound
day
result
obtain
clearli
demonstr
glycycoumarin
glycyrin
glycyrol
inhibit
hcv
rna
replic
result
decreas
hcv
protein
synthesi
demonstr
quantit
immunoblot
analys
fig
b
also
confirm
product
hcv
infecti
particl
inhibit
glycycoumarin
glycyrin
glycyrol
day
fig
glycyrrhiza
speci
possess
varieti
bioactiv
compound
triterpenoid
exampl
glycyrrhizin
glycyrrhet
acid
glycyrrhetin
acid
variou
ii
coumarin
exampl
glycycoumarin
glycyrin
glycyrol
iii
flavanon
exampl
liquiritin
liquiritigenin
iv
chalcon
exampl
isoliquiritigenin
licochalcon
v
isoflavan
exampl
glabridin
vi
stilbenoid
exampl
dihydrostilben
miscellan
compound
connect
flavanon
chalcon
isoflavan
member
flavonoid
glycyrrhizin
major
constitu
glycyrrhiza
speci
repres
total
glycyrrhizin
compound
isol
glycyrrhiza
speci
reportedli
possess
antivir
activ
varieti
virus
regard
hcv
recent
report
glycyrrhizin
inhibit
hcv
infect
cell
hand
controversi
observ
report
clinic
set
name
glycyrrhizin
signific
effect
amount
hcv
rna
wherea
reduc
serum
alanin
aminotransferas
concentr
patient
appar
contradictori
find
might
explain
effect
glycyrrhizin
clear
evid
antivir
activ
glycyrrhizin
still
lack
present
studi
observ
glycyrrhizin
glycyrrhiz
acid
monoammonium
show
margin
activ
tabl
glycyrrhetin
acid
show
signific
activ
howev
activ
significantli
weaker
hplc
fraction
obtain
g
uralensi
extract
hand
found
certain
coumarin
glycycoumarin
glycyrin
glycyrol
flavanon
liquiritigenin
isol
g
uralensi
well
compound
contain
glycyrrhiza
speci
possess
potent
activ
analysi
reveal
compound
test
act
primarili
step
consist
observ
research
also
report
two
flavonoid
isoliquiritigenin
glycycoumarin
extract
glycyrrhiza
radix
either
g
uralensi
g
glabra
inhibit
replic
hcv
subgenom
rna
replicon
vitro
valu
isoliquiritigenin
glycycoumarin
hcv
subgenom
replicon
respect
hand
best
knowledg
publish
report
far
regard
activ
glycyrin
glycyrol
report
glycyrin
known
possess
peroxisom
activ
show
antibacteri
activ
streptococcu
pyogen
haemophilu
influenza
moraxella
catarrhali
glycyrol
reportedli
exert
effect
bind
calcineurin
inhibit
activ
howev
possibl
antimicrobi
activ
glycyrol
report
studi
need
elucid
detail
mechan
activ
glycyrin
glycyrol
also
possibl
antivir
activ
virus
hcv
conclus
result
suggest
glycycoumarin
glycyrin
glycyrol
liquiritigenin
isol
g
uralensi
well
isoliquiritigenin
licochalcon
glabridin
would
good
candid
seed
compound
develop
antivir
hcv
author
conflict
interest
declar
